Delivery of therapeutic drug monitoring services: Survey of Australasian clinical pharmacology laboratories

Therapeutic Drug Monitoring

Volumn 20, Issue 6, 1998, Pages 598-601

  Morris, Raymond G ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Clinical pharmacology; Therapeutic drug monitoring

Indexed keywords

ARTICLE; AUSTRALIA; CHROMATOGRAPHY; COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HOSPITAL LABORATORY; IMMUNOASSAY; NEW ZEALAND; PRIORITY JOURNAL; QUESTIONNAIRE; TOXICITY TESTING;

AUSTRALIA; DATA COLLECTION; DRUG MONITORING; HUMANS; PHARMACOLOGY, CLINICAL; PHARMACY SERVICE, HOSPITAL; PRACTICE GUIDELINES;

EID: 0031755843     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199812000-00002     Document Type: Article

References (4)

1. Tonkin AL, Bochner F. Therapeutic drug monitoring and patient outcome. Clin Pharmacokinet 1994;27:169-74.
2. Tett SE, Ray JE, Morris RG. Best practice in therapeutic drug monitoring. ASCEPT TDM Interest Group. Sydney: HC Martyn & Son, 1995.
3. Destache CJ, Meyer SK, Bittner MJ, et al. Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: A cost benefit analysis. Ther Drug Monit 1990;12:419-26.
4. Welling R. Therapeutic drug monitoring: Down come the walls. Today's Life Sci 1994;Nov:32-7.